Your browser doesn't support javascript.
loading
Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes.
Stanworth, R D; Kapoor, D; Channer, K S; Jones, T H.
Affiliation
  • Stanworth RD; Centre for Diabetes and Endocrinology, Barnsley Hospital NHS Foundation Trust, Barnsley, South Yorkshire, UK.
Clin Endocrinol (Oxf) ; 74(5): 624-30, 2011 May.
Article in En | MEDLINE | ID: mdl-21470285
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Receptors, Androgen / Trinucleotide Repeats / Diabetes Mellitus, Type 2 / Estradiol / Dyslipidemias Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Clin Endocrinol (Oxf) Year: 2011 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Receptors, Androgen / Trinucleotide Repeats / Diabetes Mellitus, Type 2 / Estradiol / Dyslipidemias Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Clin Endocrinol (Oxf) Year: 2011 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom